Brief: Sedana Medical Q3 EBIT Loss Widens To SEK 11.7 Million
Nov 5 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* Q3 NET SALES SEK 21.4 MILLION VERSUS SEK 16.4 MILLION YEAR
AGO
* Q3 EBIT LOSS SEK 11.7 MILLION VERSUS LOSS SEK 5.1 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr5lZ2DD
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln